Notably, certain AQP4 single nucleotide polymorphisms (e.g., rs1058424, rs335929, rs3763043) are associated with more severe negative symptoms in schizophrenia and the need for higher doses of olanzapine for symptom control [175,176,177]. This evidence concerns the gene AQP4 and schizophrenia.